Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
ITOS ITeos Therapeutics
- 6.850
- -0.100-1.44%
Trading Mar 11 11:33 ET
261.63MMarket Cap-2.06P/E (TTM)
6.980High6.730Low141.82KVolume6.890Open6.950Pre Close968.30KTurnover0.49%Turnover RatioLossP/E (Static)38.19MShares18.75052wk High0.44P/B199.70MFloat Cap6.67052wk Low--Dividend TTM29.15MShs Float52.430Historical High--Div YieldTTM3.60%Amplitude6.670Historical Low6.827Avg Price1Lot Size
ITeos Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 5.37%-98.18M | 139.93%5.5M | -10.21%-37.35M | -14.83%-33.93M | -22.01%-32.4M | 6.69%-103.76M | 49.34%-13.77M | -14.12%-33.89M | 2.56%-29.55M | -10.64%-26.56M |
| Net income from continuing operations | -19.33%-134.41M | -43.08%-43.71M | -40.69%-45.36M | 79.22%-7.13M | -145.75%-38.22M | -216.54%-112.64M | -249.37%-30.55M | -3,353.28%-32.24M | -709.67%-34.3M | -122.35%-15.55M |
| Operating gains losses | ---2.06M | ---3.57M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 37.86%1.24M | 41.85%322K | 34.82%302K | 37.78%310K | 36.94%304K | 11.83%898K | 1.79%227K | 9.27%224K | 15.38%225K | 23.33%222K |
| Other non cash items | ---12K | ---3K | ---4K | ---4K | -150.00%-1K | ---- | ---- | ---- | ---- | 0.00%2K |
| Change In working capital | 311.92%18.65M | 318.98%48.4M | 126.10%1.64M | -32,159.41%-32.38M | 106.98%990K | 96.15%-8.8M | 122.21%11.55M | 82.88%-6.27M | 100.24%101K | 85.52%-14.18M |
| -Change in receivables | 114.17%1.04M | 1,777.09%38.57M | 81.09%-574K | -899.36%-37.35M | -78.09%384K | -172.50%-7.32M | -160.62%-2.3M | -249.25%-3.04M | -545.42%-3.74M | -77.38%1.75M |
| -Change in prepaid assets | 129.89%423K | -10.34%1.65M | 92.65%-173K | -269.28%-799K | -209.57%-252K | -68.81%184K | 737.85%1.84M | 32.37%-2.36M | -81.49%472K | -87.29%230K |
| -Change in payables and accrued expense | 42.81%11.97M | -48.09%5.54M | 297.27%1.52M | 46.77%4.27M | 114.61%647K | 43.04%8.38M | 33,440.63%10.67M | 93.17%-768K | 110.50%2.91M | -109.88%-4.43M |
| -Change in other working capital | 152.00%5.22M | 96.36%2.64M | 881.98%868K | 226.09%1.5M | 101.80%211K | 95.90%-10.04M | 102.43%1.35M | 99.47%-111K | 102.84%460K | 92.29%-11.74M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 5.37%-98.18M | 139.93%5.5M | -10.21%-37.35M | -14.83%-33.93M | -22.01%-32.4M | 6.69%-103.76M | 49.34%-13.77M | -14.12%-33.89M | 2.56%-29.55M | -10.64%-26.56M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -280.50%-131.15M | -77.88%13.62M | -503.16%-91.49M | -18.81%16.32M | -119.60%-69.6M | 116.29%72.66M | 113.83%61.56M | 21,712.38%22.69M | 4,011.09%20.1M | -9,712.38%-31.69M |
| Net PPE purchase and sale | 44.94%-1.63M | 89.11%-152K | 87.48%-94K | 36.86%-442K | -694.12%-945K | -216.20%-2.97M | -1,093.16%-1.4M | -804.82%-751K | -36.99%-700K | 47.58%-119K |
| Net investment purchase and sale | -271.01%-129.49M | -78.09%13.79M | -488.47%-91.4M | -19.42%16.76M | -117.43%-68.66M | 117.02%75.72M | 114.15%62.97M | --23.53M | --20.8M | ---31.58M |
| Net other investing changes | 74.75%-25K | ---- | ---- | ---- | ---- | 17.50%-99K | -1,700.00%-16K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -280.50%-131.15M | -77.88%13.62M | -503.16%-91.49M | -18.81%16.32M | -119.60%-69.6M | 116.29%72.66M | 113.83%61.56M | 21,712.38%22.69M | 4,011.09%20.1M | -9,712.38%-31.69M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 10,883.02%122.24M | -7.17%285K | -4,520.00%-442K | 56,035.78%122.38M | -96.19%22K | -43.90%1.11M | -77.66%307K | 1,100.00%10K | -21.58%218K | 73.57%578K |
| Net common stock issuance | --119.99M | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 144.74%2.72M | -10.75%274K | 360.00%46K | 992.66%2.38M | -96.19%22K | 20.32%1.11M | -2.54%307K | 1,100.00%10K | -21.58%218K | 73.57%578K |
| Net other financing activities | ---477K | --11K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 10,883.02%122.24M | -7.17%285K | -4,520.00%-442K | 56,035.78%122.38M | -96.19%22K | -43.90%1.11M | -77.66%307K | 1,100.00%10K | -21.58%218K | 73.57%578K |
| Net cash flow | ||||||||||
| Beginning cash position | -11.78%251.45M | -39.31%124.05M | 16.13%251.4M | -34.88%146.92M | -11.78%251.45M | -66.42%285.04M | -72.84%204.4M | -72.67%216.48M | -72.63%225.6M | -66.42%285.04M |
| Current changes in cash | -257.15%-107.09M | -59.67%19.4M | -1,055.65%-129.28M | 1,235.73%104.77M | -76.83%-101.98M | 94.60%-29.99M | 110.21%48.1M | 62.46%-11.19M | 69.81%-9.23M | -140.38%-57.67M |
| Effect of exchange rate changes | 46.42%-1.93M | 2.48%-1.02M | 316.20%1.94M | -358.04%-289K | -44.21%-2.55M | 57.75%-3.6M | -130.05%-1.05M | 90.94%-895K | 107.13%112K | -214.56%-1.77M |
| End cash Position | -43.36%142.43M | -43.36%142.43M | -39.31%124.05M | 16.13%251.4M | -34.88%146.92M | -11.78%251.45M | -11.78%251.45M | -72.84%204.4M | -72.67%216.48M | -72.63%225.6M |
| Free cash flow | 6.47%-99.81M | 135.25%5.35M | -8.09%-37.45M | -13.63%-34.37M | -25.01%-33.35M | 4.82%-106.72M | 44.44%-15.16M | -16.33%-34.64M | 1.90%-30.25M | -10.09%-26.67M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |